Why AI-Driven Discovery Changes Biochemical Workflows

AI-assisted drug discovery is rapidly changing how compounds are prioritized and advanced.

Instead of screening millions of compounds experimentally, many discovery teams now use AI-guided workflows, virtual screening, and computational prioritization to identify smaller sets of high-potential compounds earlier in the process.

This shift creates new opportunities — but it also increases the importance of experimental confidence. When fewer compounds enter the lab, every experimental decision matters more.

That means discovery teams increasingly need:

  • Rapid biochemical validation
  • High-confidence activity confirmation
  • Early selectivity profiling
  • Mechanism-of-action insights
  • Reliable workflows for difficult targets
  • Faster iteration between computational and experimental workflows

BellBrook Labs helps integrate high-quality biochemical assays throughout these workflows.

Managing high-throughput workflow in the lab

Why High-Confidence Biochemical Data Matters More Than Ever

Orthogonal Screening from Hits to DRCs

AI-guided prioritization can accelerate early discovery, but computational models still depend on high-quality experimental data.

False positives, assay interference, nonspecific activity, and poor selectivity remain major challenges in drug discovery — especially for complex enzyme targets.

High-confidence biochemical assays help discovery teams:

  • Confirm biologically relevant activity
  • Reduce downstream program risk
  • Generate cleaner SAR data
  • Identify selectivity issues earlier
  • Support mechanism-of-action studies
  • Improve confidence in lead progression decisions

This is especially important for enzyme classes and difficult targets where biochemical assay design directly impacts discovery success.

A virtual screening workflow may prioritize several hundred compounds computationally, followed by rapid biochemical validation, selectivity profiling, and mechanism-of-action studies to accelerate progression decisions.

Navigating Hit Prioritization After AI Screening Using Biochemical Assays

A Guide to Navigating Hit Prioritization

Get BellBrook’s practical guide to how biochemical assays can be used after screening for hit confirmation, orthogonal validation, triaging, mechanism studies, hit expansion, and residence time analysis.

This field is for validation purposes and should be left unchanged.
Name(Required)

Where BellBrook Fits Into AI-Driven Discovery Workflows

BellBrook assays and services support multiple stages of modern AI-assisted discovery workflows.

CRO & Partner Integration

Integrate BellBrook assays into CRO workflows, collaborative discovery programs, and AI-enabled screening partnerships.

Difficult Target Workflows

Support challenging enzyme classes including helicases, ATPases, GTPases, PARPs, PDEs, glycosyltransferases, and innate immunity targets.

Workflow Iteration Support

Enable rapid iteration between computational predictions and experimental validation.

Move Faster from Hits to Leads

A strong biochemical assay is more than a confirmation tool. It can support several critical steps after screening.

Check Mark Icon
Confirm Hits from AI Screening

Use an orthogonal biochemical assay to reconfirm activity in dose-response and improve confidence in apparent hits before moving further into chemistry or biology.

Protocol Icon
Triage False Positives

Identify non-stoichiometric inhibitors and other artifacts, including detergent shift, enzyme titration, and hill slope analysis. These are important tools for reducing false positives early.

Instrument Compatibility Icon
Characterize Mechanism and Potency

Post-screen biochemical assays can be used to evaluate competitive behavior, compare potency under different substrate conditions, and prioritize compounds with more confidence.

Publications Icon
Measure Residence Time

Jump-dilution biochemical assays are an alternative way to estimate inhibitor off-rates and residence time, providing another layer of post-screen differentiation.

A Strong Fit for Virtual Screening and AI-Enabled Workflows

As more teams use virtual screening and AI-guided prioritization to narrow compound sets before testing, the need for reliable biochemical validation becomes even more important.

This video is explicitly focused on how biochemical assays are used after either biochemical HTS or virtual screening, with applications in hit confirmation, triaging, hit expansion, mechanism studies, and residence time analysis.

If your team is moving from in silico prioritization to experimental validation, an orthogonal biochemical assay can help you:

  • confirm active compounds quickly
  • remove false positives before deeper investment
  • generate stronger data for progression decisions
From Virtual Hits to Validated Inhibitors: How to Confirm Virtual Screening Results

Virtual screening is a powerful approach in small-molecule drug discovery. But identifying a hit is just the beginning. To move beyond predictions, you need biochemical validation. In this video, we walk through the critical steps for confirming virtual screening hits.

BellBrook Workflow Capabilities

BellBrook assays and services support multiple stages of modern AI-assisted discovery workflows.

Transcreener Assays

Direct biochemical assays for ADP, AMP, GDP, UDP, cGAMP, and other nucleotide products with strong sensitivity and reduced assay interference.

Example targets include: kinases, ATPases, GTPases, Helicases, Glycosyltransferases, Methyltransferases, cGAS, CD39, CD73, PARPs, PARG and SIRTs.

Biochemical Services

BellBrook scientists support:

  • Assay development
  • Hit validation
  • Selectivity profiling
  • Mechanism-of-action studies
  • Difficult target workflows
  • Screening support

Workflow

Support

We work directly with biotech, pharma, CRO, and AI-driven discovery teams to integrate high-confidence biochemical assays into modern discovery workflows.

Fast-moving discovery programs require reliable biochemical data to support better decisions. Our goal is to help teams generate high-confidence experimental results and move programs forward faster.

Trusted by Over 700+ Labs Globally for 20+ Years

See What Other Scientists Are Saying About BellBrook Labs.

“The ADP assay is a great choice for measuring activity for any ADP-generating enzyme in both real time and endpoint formats. The universal detection system has been very useful for more challenging targets.”

“We were struggling with a narrow assay window and poor sensitivity with luciferase-coupled ATPase assays. Initially, we had Bellbrook run their Transcreener ATPase assay in-house as a contracted project. We were so pleased with the results that we immediately onboarded the assay to our company lab. Throughout the whole process, Bellbrook scientists were clear, rapid communicators and demonstrated their deep knowledge of the assay. We highly recommend Bellbrook to our peers in drug discovery.”

“Excellent blend of simplicity & good science. Excellent technical support”

“The assay itself has good reproducibility and provides a clear readout on our enzyme activity. The most important piece, however, is the level of attention to our project and rapid turnaround time. The staff at BellBrook knows what they are doing.”

“Through the process of developing and validating an assay for HTS applications, I generated a very nice data package of robust high quality data.”

PreviousNext

Modern Discovery Requires Integrated Experimental Workflows

AI-assisted drug discovery continues evolving rapidly, but high-quality biochemical data remains essential for advancing programs successfully.

BellBrook Labs helps discovery teams integrate reliable biochemical assays throughout modern workflows — from hit confirmation and selectivity analysis to difficult target screening and mechanism-of-action studies.

Our goal is simple: Help discovery teams make faster, higher-confidence biochemical decisions.

AI-Driven Biotech Discovery In Action

Looking to Integrate Biochemical Assays Into AI-Driven Discovery Workflows?

Whether you are validating AI-prioritized hits, developing difficult target assays, or building integrated discovery workflows, BellBrook scientists are here to help.

This field is for validation purposes and should be left unchanged.
Name(Required)

We understand that confidentiality in this business is critical. Our goal is to accelerate your discovery by providing the best solution available, coupled with expert support. We can fast track an NDA if desired.

BellBrook Labs logo

BellBrook Labs
1232 Fourier Drive, Suite 115
Madison, Wisconsin 53717 USA
(608) 443-2400

info@bellbrooklabs.com